BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 9808713)

  • 1. Disruption of insulin-like growth factor-1 signaling and down-regulation of cdc2 by SC-alphaalphadelta9, a novel small molecule antisignaling agent identified in a targeted array library.
    Vogt A; Rice RL; Settineri CE; Yokokawa F; Yokokawa S; Wipf P; Lazo JS
    J Pharmacol Exp Ther; 1998 Nov; 287(2):806-13. PubMed ID: 9808713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo antitumor activity and induction of insulin-like growth factor-1-resistant apoptosis by SC-alphaalphadelta9.
    Vogt A; Wang AS; Johnson CS; Fabisiak JP; Wipf P; Lazo JS
    J Pharmacol Exp Ther; 2000 Feb; 292(2):530-7. PubMed ID: 10640289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual G1 and G2/M phase inhibition by SC-alpha alpha delta 9, a combinatorially derived Cdc25 phosphatase inhibitor.
    Tamura K; Rice RL; Wipf P; Lazo JS
    Oncogene; 1999 Nov; 18(50):6989-96. PubMed ID: 10597298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A chimeric humanized single-chain antibody against the type I insulin-like growth factor (IGF) receptor renders breast cancer cells refractory to the mitogenic effects of IGF-I.
    Sachdev D; Li SL; Hartell JS; Fujita-Yamaguchi Y; Miller JS; Yee D
    Cancer Res; 2003 Feb; 63(3):627-35. PubMed ID: 12566306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MPF amplification in Xenopus oocyte extracts depends on a two-step activation of cdc25 phosphatase.
    Karaïskou A; Cayla X; Haccard O; Jessus C; Ozon R
    Exp Cell Res; 1998 Nov; 244(2):491-500. PubMed ID: 9806800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Formation of distinct signalling complexes involving phosphatidylinositol 3-kinase activity with stimulation of epidermal growth factor or insulin-like growth factor-I in human skin fibroblasts.
    Takahashi Y; Akanuma Y; Yazaki Y; Kadowaki T
    J Cell Physiol; 1999 Jan; 178(1):69-75. PubMed ID: 9886492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Muscarinic-receptor-mediated inhibition of insulin-like growth factor-1 receptor-stimulated phosphoinositide 3-kinase signalling in 1321N1 astrocytoma cells.
    Batty IH; Fleming IN; Downes CP
    Biochem J; 2004 May; 379(Pt 3):641-51. PubMed ID: 14769130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A targeted library of small-molecule, tyrosine, and dual-specificity phosphatase inhibitors derived from a rational core design and random side chain variation.
    Rice RL; Rusnak JM; Yokokawa F; Yokokawa S; Messner DJ; Boynton AL; Wipf P; Lazo JS
    Biochemistry; 1997 Dec; 36(50):15965-74. PubMed ID: 9398331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro and in vivo antitumor effects of the dual insulin-like growth factor-I/insulin receptor inhibitor, BMS-554417.
    Haluska P; Carboni JM; Loegering DA; Lee FY; Wittman M; Saulnier MG; Frennesson DB; Kalli KR; Conover CA; Attar RM; Kaufmann SH; Gottardis M; Erlichman C
    Cancer Res; 2006 Jan; 66(1):362-71. PubMed ID: 16397250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of cdc25-C phosphatase in the immediate G2 delay induced by the exogenous factors epidermal growth factor and phorbolester.
    Barth H; Hoffmann I; Klein S; Kaszkin M; Richards J; Kinzel V
    J Cell Physiol; 1996 Sep; 168(3):589-99. PubMed ID: 8816913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transformation by the simian virus 40 T antigen is regulated by IGF-I receptor and IRS-1 signaling.
    DeAngelis T; Chen J; Wu A; Prisco M; Baserga R
    Oncogene; 2006 Jan; 25(1):32-42. PubMed ID: 16170362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dual regulation of upstream binding factor 1 levels by IRS-1 and ERKs in IGF-1-receptor signaling.
    Sun H; Tu X; Liu M; Baserga R
    J Cell Physiol; 2007 Sep; 212(3):780-6. PubMed ID: 17443674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A fully human monoclonal antibody to the insulin-like growth factor I receptor blocks ligand-dependent signaling and inhibits human tumor growth in vivo.
    Burtrum D; Zhu Z; Lu D; Anderson DM; Prewett M; Pereira DS; Bassi R; Abdullah R; Hooper AT; Koo H; Jimenez X; Johnson D; Apblett R; Kussie P; Bohlen P; Witte L; Hicklin DJ; Ludwig DL
    Cancer Res; 2003 Dec; 63(24):8912-21. PubMed ID: 14695208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Arrest at the G2/M transition of the cell cycle by protein-tyrosine phosphatase inhibition: studies on a neuronal and a glial cell line.
    Faure R; Vincent M; Dufour M; Shaver A; Posner BI
    J Cell Biochem; 1995 Nov; 59(3):389-401. PubMed ID: 8567756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin-like growth factor type-I receptor-dependent phosphorylation of extracellular signal-regulated kinase 1/2 but not Akt (protein kinase B) can be induced by picropodophyllin.
    Vasilcanu R; Vasilcanu D; Sehat B; Yin S; Girnita A; Axelson M; Girnita L
    Mol Pharmacol; 2008 Mar; 73(3):930-9. PubMed ID: 18070930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of histone H1 kinase expression, retinoblastoma protein phosphorylation, and cell proliferation by the phosphatase inhibitor okadaic acid.
    Schönthal A; Feramisco JR
    Oncogene; 1993 Feb; 8(2):433-41. PubMed ID: 8381221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of cell-cycle regulatory signaling network by 2-methoxyestradiol in prostate cancer cells is mediated through multiple signal transduction pathways.
    Ray G; Dhar G; Van Veldhuizen PJ; Banerjee S; Saxena NK; Sengupta K; Banerjee SK
    Biochemistry; 2006 Mar; 45(11):3703-13. PubMed ID: 16533053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of in vivo breast cancer growth by antisense oligodeoxynucleotides to type I insulin-like growth factor receptor mRNA involves inactivation of ErbBs, PI-3K/Akt and p42/p44 MAPK signaling pathways but not modulation of progesterone receptor activity.
    Salatino M; Schillaci R; Proietti CJ; Carnevale R; Frahm I; Molinolo AA; Iribarren A; Charreau EH; Elizalde PV
    Oncogene; 2004 Jul; 23(30):5161-74. PubMed ID: 15122317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of CDC2 from etoposide-treated cells as substrate to assay CDC25 phosphatase activity.
    Cans C; Sert V; De Rycke J; Baldin V; Ducommun B
    Anticancer Res; 1999; 19(2A):1241-4. PubMed ID: 10368682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of cdc2, cdc25 and cyclin A genes in the maintenance of immortalization and growth arrest in a rat embryonic fibroblast conditional cell line.
    Gonos ES; Spandidos DA
    Cell Biol Int; 1996 Mar; 20(3):159-67. PubMed ID: 8673064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.